| Value | ₹0.39 Cr |
|---|
NSE filing, NSE: NORTHARC. Summary written from the filing by ALFA Finder's alert engine.
Northern Arc Capital Ltd: key numbers
- Share price
- ₹256.50
- Market cap
- ₹4,150 Cr
- Revenue (annual)
- ₹2,690 Cr
- Net profit (annual)
- ₹406.0 Cr
- P/E (TTM)
- 9.4×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Northern Arc Capital Ltd
All →Northern Arc Capital Board Meeting Date
Northern Arc Capital has scheduled its Board Meeting for November 3, 2026, to approve Q2 and H1 FY27 unaudited results. Trading window closes November 5, 2026.
Northern Arc Capital Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Listing Regulations.
Northern Arc Capital Employee Stock Options
Northern Arc Capital Limited has allotted 3,000 equity shares of Rs. 10 each to employees upon exercise of stock options under its ESOP scheme.
Northern Arc Capital Employee Stock Options
Northern Arc Capital allotted 1,44,000 ESOP shares to option grantees under its 2016 plan. Paid-up equity capital increased to Rs. 161.81 Crore.
Northern Arc Capital Other Announcement
Northern Arc Capital Limited submitted its monthly Asset Liability Management (ALM) statement for July 2026 to the Reserve Bank of India, as mandated by regulatory requirements.
Northern Arc Capital Capital Structure Change
Northern Arc Capital Limited allotted equity shares under its ESOP scheme. The allotment results in a minor increase in the company's paid-up share capital.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date